Bread sold at Kroger and Walmart in a dozen states is under recall for ‘life-threatening' problem
Hartford Bakery Inc. recalled its Lewis Bake Shop Artisan Style half-loaf bread after an internal packaging error resulted in visible hazelnuts, an undeclared allergen, in some loaves.
About 883 units from six production lots were mistakenly wrapped and labeled merely as 'May Contain Tree Nuts,' without specifying hazelnuts.
The contamination stems from a packaging changeover from a hazelnut-containing bread batch to the white loaf variant, the company said.
The recalled bread was distributed across 12 states, including Michigan, Wisconsin, Illinois, Indiana, Ohio, Kentucky, Tennessee, Georgia, Arkansas, Missouri, Alabama and Mississippi.
The company, headquartered in West Hartford, Connecticut, issued a recall for its 'Lewis Bake Shop Artisan Style 1/2 Loaf' on July 10, according to the FDA. The company warns that "people with a nut allergy or severe sensitivity to hazelnuts run the risk of serious or life-threatening allergic reactions" if they consume the bread.
The bread is packaged in a flexible plastic bag and can be identified by lot codes T10 174010206, T10 174010306, T10 174010406, T10 174020206, T10 174020306 and T10 174020406, which appear on the front panel.
The packaging also includes a net weight of 12 oz, a UPC of 24126018152 on the bottom and an expiration date of 07/13/2025 displayed on the front panel.
Hartford Bakery said it had removed all products linked to the six affected production lots.
The bakery had received complaints about visible nuts and reports one case of digestive discomfort, but no serious injuries or illnesses have been reported.
Consumers who have purchased the affected product are being urged to return it to the place of purchase for a full refund.
Solve the daily Crossword
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
New York Times
an hour ago
- New York Times
Two Days Inside the Movement to ‘Reindustrialize,' and Rearm, America
Investors from Silicon Valley and senior officials in the Trump administration descended on a convention hall in downtown Detroit last week for a conference committed to spurring a 'techno-industrial renaissance' in the United States. In some ways, it looked like a normal convention. The makers of everything from carbon brushes to boat propellers milled around a large hall, looking at a flying boat, a customizable electric truck, an air taxi and a humanoid robot. But at times, it turned into an urgent and literal call to arms as discussions moved from manufacturing to national security. 'You will help us forge a future where we can build and sustain an industrial base that can deliver the critical weapons we need, fast and at scale,' Defense Secretary Pete Hegseth told the participants in a video message. 'Time is short.' The two-day summit, Reindustrialize 2025, was put on by an ad hoc group that met through Atomic Industries, a manufacturing firm in Warren, Mich. The convention's founders include Atomic's chief executive, Aaron Slodov, who last year penned 'A Techno-Industrialist Manifesto,' which called on investors and the tech community to focus on manufacturing physical goods. About 1,200 people attended the conference, about twice the number who attended the first gathering last year, said Falon Donohue, an Atomic board member who is also a founder of the conference. Thousands were on the waiting list, she said. More than 16,000 watched the speeches, round tables and fireside chats online. Want all of The Times? Subscribe.
Associated Press
3 hours ago
- Associated Press
UNCY Investors Have Opportunity to Join Unicycive Therapeutics, Inc. Fraud Investigation With the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)--Jul 19, 2025-- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Unicycive Therapeutics, Inc. ('Unicycive' or 'the Company') (NASDAQ: UNCY ) for violations of the securities laws. The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. Unicycive announced on June 30, 2025, that the FDA 'has issued a CRL [Complete Response Letter] for its New Drug Application (NDA) for OLC to treat hyperphosphatemia in patients with chronic kidney disease (CKD) on dialysis.' The Company added that 'After submitting the NDA, and as a part of the application review and routine information requests, the FDA notified Unicycive that a third-party manufacturing vendor of its main contract development and manufacturing organization (CDMO) was cited for deficiencies following a cGMP inspection.' Based on this news, shares of Unicycive fell by 29.85% on the same day. If you are a shareholder who suffered a loss, click here to participate. We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at or by email at [email protected]. The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation. This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics. View source version on CONTACT: The Schall Law Firm Brian Schall, Esq. 310-301-3335 [email protected] KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA INDUSTRY KEYWORD: CLASS ACTION LAWSUIT PROFESSIONAL SERVICES LEGAL SOURCE: Schall Law Firm Copyright Business Wire 2025. PUB: 07/19/2025 02:19 PM/DISC: 07/19/2025 02:19 PM
Yahoo
4 hours ago
- Yahoo
Ford Keeps Disappointing Investors in This Key Factor -- and 1 Graph You Have to See
Key Points Ford's 90 recalls so far in 2025 already sets a record. Recalls don't typically impact auto stocks, but there are exceptions. This recall will incur a special item on earnings, not impacting adjusted earnings. 10 stocks we like better than Ford Motor Company › Ford Motor Company (NYSE: F) is known for many things, including championing the moving assembly line that drastically changed the automotive industry in its infancy. It's also known for its lucrative dividend, trudging through the financial crisis without a government bailout, and producing more vehicles in the U.S. than its Detroit rivals. Unfortunately, Ford is also becoming known for something less desirable: recalls and warranty costs, and it's been a problem for years. Let's take a look at Ford's recent recall and how much it'll dent earnings. Recalls. Recalls everywhere. Let's first make a note of something: Recalls are simply a part of business in the automotive industry. Typically, recalls don't tend to impact automotive stocks. In fact, when the vehicle is sold the automaker essentially estimates what the future cost of warranty coverage will be, and sets aside cash to handle such business. The problem is when warranty costs exceed, or greatly exceed, original estimates -- that's when excess costs can add up and weigh on the bottom line. That said, Ford's recent recall for nearly 700,000 crossovers in the U.S., due to a fuel leak issue that could increase the risk of a fire, is the automaker's 90th recall already in 2025 -- a staggering number. Ford's 90 recalls so far this year are more than the next five manufacturers combined, and already set a full-year record for an individual automaker, breaking General Motors' previous record of 77 recalls in 2014 amid its massive ignition switch scandal, according to the National Highway Traffic Safety Administration (NHTSA). To be fair, not all recalls are created equal, and issues that can be fixed with an over-the-air software update hardly cost the company a thing. On the flip side, when a vehicle has to be serviced, parts adjusted, or other manual labor is required, expenses can add up fast. So it's a bit unfair to draw any drastic conclusions solely from 90 recalls without knowing further details. Ford said 33 of its recalls so far in 2025 were related to software audits implemented in March, which should be far less costly than other recalls. If you recall (no pun intended), last year during the second quarter warranty costs checked in $800 million higher compared to the prior year, which caused Ford to miss earnings and sent its stock lower. This recent recall shouldn't cause a similar result, for the most part. What's the damage? Ford said the recall remedy will cost the company roughly $570 million and will be included in the second-quarter earnings report as a "special item." For investors, this means that the increase in warranty expenses won't impact the company's adjusted earnings (which is what Wall Street estimates), adjusted earnings per share (EPS), or adjusted free cash flow. In the early 2000s Ford's warranty payments compared to revenue was at a much lower percentage. That spiked to about 4% during last year's second quarter, a high number for automakers, when the company notoriously took a hit for higher warranty costs. Let's look at some longer trends. Here are Ford's warranty payments as a percentage of revenue over the past 20 years. For a quick comparison, rival General Motors' warranty payments as a percentage of revenue checked in at 2.4% and 2.3% in 2024 and 2023, respectively. Ford has stood firm that it's making significant quality improvements and noted that 2024 model years, during the first three months of service, were 30% better in quality compared to prior years. Currently, Ford's warranty costs and quality issues are one of the biggest uncertainties facing investors. Ford is saying all the right things, and supposedly doing all the right things to fix quality, but so far investors have been left disappointed. It's certainly something to note in your Ford investment thesis, and recalls and warranty costs will be something to keep your eye on over the next 18 months as, hopefully, quality improvements filter through and recalls decline. Should you buy stock in Ford Motor Company right now? Before you buy stock in Ford Motor Company, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Ford Motor Company wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $652,133!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,056,790!* Now, it's worth noting Stock Advisor's total average return is 1,048% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 15, 2025 Daniel Miller has positions in Ford Motor Company. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Ford Keeps Disappointing Investors in This Key Factor -- and 1 Graph You Have to See was originally published by The Motley Fool Sign in to access your portfolio
